Sir,

Sexually transmitted diseases (STDs) remain a public health problem of major significance in most part of the world. India has the second highest number of people living with human immunodeficiency virus (HIV).\[[@ref1]\] The presence of genital ulcers (syphilis) significantly increases the transmission of HIV to sexual partner. Recent outbreaks of syphilis and increase in hepatitis B cases have raised concern regarding the potential enhancement of STDs. It has recently been found that HIV-positive patients with hepatitis B virus (HBV) co-infection are associated with increased risk of progression to severe hepatotoxicity due to antiretroviral therapy (ART) and reduced survival of the patient.\[[@ref2]\] Therefore, there is a serious need to consider anti-HBV therapy in addition to ART in those with dual infection.

This prospective study was conducted to identify the prevalence of syphilis and hepatitis B among 500 patients attending sexually transmitted infection (STI) clinic and ART clinic (250 patients each) of S.N. Medical College, Agra, Uttar Pradesh, India from March 2014 to January 2015. Serological screening, venereal disease research laboratory, and rapid plasma reagin for syphilis and hepatitis B surface antigen (HBsAg) *in vitro* immunochromatographic test for hepatitis B were done. HIV testing was done on STI attendees as per NACO guidelines.

Among 250 STI patients, 5 (2.0%) were HBsAg positive, 2 (0.8%) were positive for syphilis, and 1 (0.4%) were positive for HIV.

From 250 HIV positive (ART) patients, 14 (5.6%) were positive for HBsAg, and 5 (2.0%) were positive for syphilis.

In our study, the prevalence of syphilis in ART patients and STI patients was 5 (2.0%) and (0.8%), respectively. However, Kyriaks *et al*. reported the prevalence of syphilis among 7.8% of ART patients, may be due to unawareness in patients.

HBsAg prevalence in STI attendees was very low (2%) in our study. However, higher prevalence (8.8%) of HBsAg co-infection was found in study by Risbud *et al*.\[[@ref3]\]

The present study showed 5.6% prevalence of HBsAg in ART attendees which are in concordance with 4.9% prevalence in study by Ahuja *et al*.\[[@ref4]\] A very high prevalence of 19.5% co-infection of HBV in a study in from Rajkot,\[[@ref5]\] and 10% of HBV co-infection was observed in study performed in Maharashtra, the state with high HIV patients load. Thus, HbsAg co-infection with HIV patients varies in different parts of India. This difference in prevalence in co-infection may be because of the stage of disease and different geographical area among HIV patients in study group.

HIV-positive patients were more likely than HIV-negative to be infected with syphilis (2% vs. 0.8%, respectively) as well as hepatitis B (5.6% vs. 2.0%, respectively).

Overall, the prevalence of co-infection of hepatitis B and syphilis were found higher in ART attendees than the STI attendees. Therefore, this study does not necessities the need for a routine screening test for syphilis and hepatitis B in patients attending STI clinic in a resource poor country like India. However, HIV-infected individuals with high probability of getting co-infected with HBV and syphilis should be considered for screening as a routine protocol.
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